These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11414165)

  • 1. [Roaming through methodology. XXXIII. Ethics of sample size estimation: less subjects needed for a one-sided than for a two-sided statistical investigation].
    Knottnerus JA; Bouter LM
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1051-4. PubMed ID: 11414165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
    Dann RS; Koch GG
    Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a mis-specification of the response rate under standard treatment in sequential clinical trials.
    Sébille V; Bellissant E
    Fundam Clin Pharmacol; 2005 Oct; 19(5):569-78. PubMed ID: 16176336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple comparisons with a control in families with both one-sided and two-sided hypotheses.
    Cheung SH; Kwong KS; Chan WS; Leung SP
    Stat Med; 2004 Oct; 23(19):2975-88. PubMed ID: 15351956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethics of sample size: two-sided testing and one-sided thinking.
    Knottnerus JA; Bouter LM
    J Clin Epidemiol; 2001 Feb; 54(2):109-10. PubMed ID: 11166523
    [No Abstract]   [Full Text] [Related]  

  • 10. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size calculations in surgery: are they done correctly?
    Maggard MA; O'Connell JB; Liu JH; Etzioni DA; Ko CY
    Surgery; 2003 Aug; 134(2):275-9. PubMed ID: 12947329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative to the use of two-sided tests in clinical trials.
    Dunnett CW; Gent M
    Stat Med; 1996 Aug; 15(16):1729-38. PubMed ID: 8870155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tricks, devices, expedients and stratagems in the management and interpretation of cardiological trials].
    Frea S; Bobbio M
    G Ital Cardiol (Rome); 2006 Nov; 7(11):761-7. PubMed ID: 17216918
    [No Abstract]   [Full Text] [Related]  

  • 14. Designing clinical trials and experiments efficiently with the program package CADEMO.
    Rasch D; Kubinger KD
    Contemp Clin Trials; 2009 Jul; 30(4):354-65. PubMed ID: 19341821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aspects of sample size determination and power calculation illustrated on examples from rehabilitation research].
    Kutschmann M; Bender R; Grouven U; Berg G
    Rehabilitation (Stuttg); 2006 Dec; 45(6):377-84. PubMed ID: 17123220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates, power and sample size calculations for two-sample ordinal outcomes under before-after study designs.
    Strickland PA; Lu SE
    Stat Med; 2003 Jun; 22(11):1807-18. PubMed ID: 12754716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving efficiency of ALS clinical trials using lead-in designs.
    Moore DH; Miller RG
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():57-60. PubMed ID: 15512875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On changing a long-term clinical trial midstream.
    Wittes J
    Stat Med; 2002 Oct; 21(19):2789-95. PubMed ID: 12325094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in designing flexible trials.
    Posch M; Bauer P; Brannath W
    Stat Med; 2003 Mar; 22(6):953-69. PubMed ID: 12627412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of clinical studies suggests those with multiple objectives should have at least 90% power for each endpoint.
    Borm GF; Houben RM; Welsing PM; Zielhuis GA
    J Clin Epidemiol; 2006 Jan; 59(1):1-6. PubMed ID: 16360554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.